Doximity Comprehensive Income 2020-2024 | DOCS

Doximity comprehensive income from 2020 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Doximity comprehensive income for the quarter ending December 31, 2024 was $0.001B, a 121.81% decline year-over-year.
  • Doximity comprehensive income for 2024 was $-0.003B, a 81.08% decline from 2023.
  • Doximity comprehensive income for 2023 was $-0.014B, a 7.92% decline from 2022.
  • Doximity comprehensive income for 2022 was $-0.015B, a 72728.57% increase from 2021.
Doximity Annual Comprehensive Income
(Millions of US $)
2024 $-3
2023 $-14
2022 $-15
2021 $0
2020 $0
2019 $0
Doximity Quarterly Comprehensive Income
(Millions of US $)
2024-12-31 $1
2024-09-30 $3
2024-06-30 $-1
2024-03-31 $-3
2023-12-31 $-5
2023-09-30 $-9
2023-06-30 $-12
2023-03-31 $-14
2022-12-31 $-19
2022-09-30 $-22
2022-06-30 $-18
2022-03-31 $-15
2021-12-31 $-4
2021-09-30 $-1
2021-06-30 $0
2021-03-31 $0
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-03-31
Sector Industry Market Cap Revenue
Medical Medical Services $11.396B $0.475B
Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.728B 26.96
Elevance Health (ELV) United States $94.145B 12.15
CVS Health (CVS) United States $81.986B 10.19
Cencora (COR) United States $53.983B 18.77
Natera (NTRA) United States $21.477B 0.00
DiDi Global (DIDIY) China $21.462B 32.57
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.941B 13.70
EUROFINS SCIENT (ERFSF) Luxembourg $12.036B 0.00
Revvity (RVTY) United States $11.610B 19.98
ICON (ICLR) Ireland $11.324B 10.53
CochLear (CHEOY) Australia $11.195B 0.00
Viatris (VTRS) United States $10.516B 3.61
Medpace Holdings (MEDP) United States $9.017B 23.95
Avantor (AVTR) United States $8.859B 12.87
HealthEquity (HQY) United States $8.361B 41.13
Sonic Healthcare (SKHHY) Australia $8.215B 0.00
Charles River Laboratories (CRL) United States $7.027B 13.77
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.202B 24.77
BrightSpring Health Services (BTSG) United States $3.894B 36.05
Sotera Health (SHC) United States $3.832B 21.77
Surgery Partners (SGRY) United States $2.982B 38.77
Alignment Healthcare (ALHC) United States $2.952B 0.00
Concentras Parent (CON) United States $2.771B 16.01
Organon (OGN) United States $2.264B 2.41
Ardent Health Partners (ARDT) United States $2.121B 9.04
Premier (PINC) United States $2.101B 14.38
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.698B 0.00
GeneDx Holdings (WGS) United States $1.683B 64.83
GoodRx Holdings (GDRX) United States $1.669B 31.07
Teladoc Health (TDOC) United States $1.289B 0.00
Pediatrix Medical (MD) United States $1.234B 9.39
Agilon Health (AGL) United States $1.229B 0.00
Establishment Labs Holdings (ESTA) $1.000B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.911B 14.23
AMN Healthcare Services Inc (AMN) United States $0.866B 8.11
Embecta (EMBC) United States $0.725B 4.89
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.689B 13.50
Enhabit (EHAB) United States $0.530B 43.58
InnovAge Holding (INNV) United States $0.513B 0.00
Auna S.A (AUNA) Luxembourg $0.513B 13.59
Sonida Senior Living (SNDA) United States $0.512B 0.00
LifeMD (LFMD) United States $0.389B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
SBC Medicals (SBC) United States $0.359B 0.00
Beauty Health (SKIN) United States $0.220B 0.00
Performant Healthcare (PHLT) United States $0.202B 0.00
Oncology Institute (TOI) United States $0.193B 0.00
DocGo (DCGO) United States $0.147B 24.08
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
KindlyMD (KDLY) United States $0.082B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.053B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
ModivCare (MODV) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00